Regulators need to learn more about the excessive sedation triggered in some patients by a longer-lasting version of Eli Lilly and Co.'s top-selling drug Zyprexa before they can approve the treatment.

Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug. The two patients, given ...

In these trials, olanzapine LAI was found to be similar to olanzapine oral in terms of rate of symptom exacerbation and showed a similar safety profile as the oral formulation with the exception of ...

INDIANAPOLIS Eli Lilly reported the receipt of a not-approvable letter on Thursday from the Food and Drug Administration for Zyprexa long-acting injection for the treatment and maintenance treatment ...

The Food and Drug Administration (FDA) stated that study results were inconclusive regarding the investigation of two deaths following the injection of Zyprexa Relprevv (olanzapine pamoate ...

PISCATAWAY, N.J. — A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a ...

December 15, 2009 — The US Food and Drug Administration (FDA) has approved olanzapine extended-release intramuscular injection (Zyprexa Relprevv, Eli Lilly & Company) for the treatment of ...

PISCATAWAY, N.J., July 30, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in ...